Neutrophil Recruitment and Barrier Impairment in Celiac Disease: A Genomic Study  Begoña Diosdado, Harm van Bakel, Eric Strengman, Lude Franke, Erica van.

Slides:



Advertisements
Similar presentations
Risk of Neoplasia After Colectomy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis Lauranne A.A.P. Derikx, Loes H.C.
Advertisements

Diet Improves Perception of Health and Well-being in Symptomatic, but Not Asymptomatic, Patients With Celiac Disease  Anniina Ukkola, Markku Mäki, Kalle.
Effect of Elemental Diet on Mucosal Immunopathology and Clinical Symptoms in Type 1 Refractory Celiac Disease  Richard Willfred Olaussen, Astrid Løvik,
Volume 130, Issue 2, Pages (February 2006)
Volume 115, Issue 3, Pages (September 1998)
Volume 138, Issue 2, Pages e3 (February 2010)
Effect of Elemental Diet on Mucosal Immunopathology and Clinical Symptoms in Type 1 Refractory Celiac Disease  Richard Willfred Olaussen, Astrid Løvik,
Saurabh Dawra, Vishal Sharma, Usha Dutta 
Volume 144, Issue 5, Pages e10 (May 2013)
Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D
Volume 140, Issue 2, Pages e2 (February 2011)
Abnormal intestinal intraepithelial lymphocytes in refractory sprue
Millie D. Long, Bruce E. Sands 
Ghazaleh Aram, Theodore M. Bayless, Zong–Ming Chen, Elizabeth A
Microarray-Based Prediction of Tumor Response to Neoadjuvant Radiochemotherapy of Patients With Locally Advanced Rectal Cancer  Caroline Rimkus, Jan Friederichs,
Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis  Alex Straumann, Sebastien Conus, Lukas Degen,
Circulating MicroRNAs as Biomarkers of Colorectal Cancer: Results From a Genome- Wide Profiling and Validation Study  María Dolores Giráldez, Juan José.
Patients With Celiac Disease Have an Increased Risk for Pancreatitis
Volume 154, Issue 4, Pages e6 (March 2018)
Long-Term Budesonide Maintenance Treatment Is Partially Effective for Patients With Eosinophilic Esophagitis  Alex Straumann, Sebastien Conus, Lukas Degen,
Anna Krigel, Kevin O. Turner, Govind K. Makharia, Peter H. R
What Is the Role of Serologic Testing in Celiac Disease
Nicholas S. Coleman, Stephen Foley, Simon P
Volume 134, Issue 4, Pages (April 2008)
Volume 133, Issue 4, Pages (October 2007)
Celiac Disease and Persistent Symptoms
A Shocking Cystory Clinical Gastroenterology and Hepatology
Volume 134, Issue 4, Pages e2 (April 2008)
Malabsorption Work-up: Utility of Small Bowel Biopsy
Right Upper Quadrant Pain and a Normal Abdominal Ultrasound
Prevalence of Irritable Bowel Syndrome–type Symptoms in Patients With Celiac Disease: A Meta-analysis  Anita Sainsbury, David S. Sanders, Alexander C.
Interleukin 15 mediates epithelial changes in celiac disease
Adult Autoimmune Enteropathy: Mayo Clinic Rochester Experience
Diet Improves Perception of Health and Well-being in Symptomatic, but Not Asymptomatic, Patients With Celiac Disease  Anniina Ukkola, Markku Mäki, Kalle.
Volume 115, Issue 3, Pages (September 1998)
Volume 133, Issue 3, Pages (September 2007)
Mucosal Healing in Patients With Celiac Disease and Outcomes of Pregnancy: A Nationwide Population-Based Study  Benjamin Lebwohl, Olof Stephansson, Peter.
Laurent Peyrin–Biroulet, Aude Bressenot, Wendy Kampman 
Volume 142, Issue 5, Pages e4 (May 2012)
Issue Highlights Clinical Gastroenterology and Hepatology
Shadi Rashtak, Michael W. Ettore, Henry A. Homburger, Joseph A. Murray 
Celiac Disease With Mild Enteropathy Is Not Mild Disease
Personalizing Colorectal Cancer Screening: A Systematic Review of Models to Predict Risk of Colorectal Neoplasia  Gene K. Ma, Uri Ladabaum  Clinical Gastroenterology.
Srinadh Komanduri, Patrick M
Ian R. Gooding, Roger Springall, Ian C. Talbot, David B.A. Silk 
Volume 138, Issue 2, Pages e3 (February 2010)
Activity-Based Costing and Management in a Hospital-Based GI Unit
Microscopic Esophageal Mucosal Injury in Nonerosive Reflux Disease
Amie L. Harvey, Tommy Yen, Anand Kunda 
Gluten-Free Diet and Steroid Treatment Are Effective Therapy for Most Patients With Collagenous Sprue  Alberto Rubio–Tapia, Nicholas J. Talley, Suryakanth.
Volume 137, Issue 6, Pages e5 (December 2009)
Microscopic Esophageal Mucosal Injury in Nonerosive Reflux Disease
Peter Bytzer  Clinical Gastroenterology and Hepatology 
Patients With Celiac Disease Are Not Followed Up Adequately
Mucosal Atrophy in Celiac Disease: Extent of Involvement, Correlation With Clinical Presentation, and Response to Treatment  Joseph A. Murray, Alberto.
Volume 130, Issue 2, Pages (February 2006)
Regional Patterns of Olmesartan Prescription and the Prevalence of Duodenal Villous Atrophy Throughout the United States  Eugenia N. Uche-Anya, Peter.
Endoscopic Ultrasound and Endoscopic Mucosal Resection Features of a Non–Protein Losing Form of Ménétrier's Disease  Ferga C. Gleeson, Thomas F. Mangan,
Hepatic Cyst? Clinical Gastroenterology and Hepatology
This Month in Gastroenterology
Synthesis of Collagen I in Collagenous Sprue
Substantial Variability in Biopsy Practice Patterns Among Gastroenterologists for Suspected Eosinophilic Gastrointestinal Disorders  Evan S. Dellon, MD,
A 27-Year-Old Woman With Constipation: Diagnosis and Treatment
Clinical and Molecular Factors Associated With Histologic Response to Topical Steroid Treatment in Patients With Eosinophilic Esophagitis  Swathi Eluri,
Volume 136, Issue 7, Pages (June 2009)
Issue Highlights Clinical Gastroenterology and Hepatology
Shradha Agarwal, Lloyd Mayer  Clinical Gastroenterology and Hepatology 
Rintaro Hashimoto, Akimichi Chonan 
Adverse Outcomes: Why Bad Things Happen to Good People
Rintaro Hashimoto, Akimichi Chonan 
Presentation transcript:

Neutrophil Recruitment and Barrier Impairment in Celiac Disease: A Genomic Study  Begoña Diosdado, Harm van Bakel, Eric Strengman, Lude Franke, Erica van Oort, Chris J. Mulder, Cisca Wijmenga, Martin C. Wapenaar  Clinical Gastroenterology and Hepatology  Volume 5, Issue 5, Pages 574-581.e5 (May 2007) DOI: 10.1016/j.cgh.2006.11.014 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Profiles of differentially expressed immune-related genes during mucosal recovery. The pattern of expression of 27 immune-related genes selected by MAANOVA analysis showed a gradual change as opposed to the discrete histologic transitions during remission. The upper panel shows the relative expression of genes that either were enhanced (red) or decreased (green) during remission. Expression was normalized to the values measured in untreated Marsh III patients. The lower panels show the corresponding histology and Marsh classification of the biopsy samples taken before treatment and during remission on a gluten-free diet. Histopathologic features include villous atrophy (MIII), crypt hyperplasia (MIII–MII), and lymphocytosis (MIII–MI). Patients in complete remission (M0) are comparable with controls. miii-ut, Marsh III untreated; miii-t, Marsh III treated; mii, Marsh II; mi, Marsh I; m0, Marsh 0. The numbers of independent individuals included in each group are indicated. Clinical Gastroenterology and Hepatology 2007 5, 574-581.e5DOI: (10.1016/j.cgh.2006.11.014) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 Immunohistochemical localization of HLA-E and MPO in the duodenal mucosa of celiac patients and controls. Shown is the expression of the nonclassic major histocompatibility complex class I molecule HLA-E and the neutrophil-specific marker MPO in patients (Marsh III and Marsh 0) and healthy controls. (A) HLA-E was expressed strongly in the Marsh III epithelial layer but absent in normalized patients (Marsh 0) and controls. No differences in staining were found at the lamina propria. (B) Increased number of MPO-positive cells in the lamina propria of Marsh III and Marsh 0 patients compared with controls. This indicated a higher number of neutrophils in the celiac mucosa regardless of the histologic stage or the gluten-free diet followed. Clinical Gastroenterology and Hepatology 2007 5, 574-581.e5DOI: (10.1016/j.cgh.2006.11.014) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 Relative expression of (A) CYP4F2 and (B) CYP4F3 determined by qRT-PCR. Gene expression was measured with qRT-PCR on RNA from individual M0 (n = 16) and MIII (n = 13) biopsy samples. Data were averaged and normalized to that obtained from a pool of complementary DNAs (n = 16) derived from normal controls (nc). Error bars indicate SDs. Measurements were in duplicate. Clinical Gastroenterology and Hepatology 2007 5, 574-581.e5DOI: (10.1016/j.cgh.2006.11.014) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 Fraction of the MPO-positive neutrophils counted in mucosal sections of celiac patients (MIII and M0) and controls. On average, a 2-fold increase in neutrophils was observed in both active and remission patients compared with healthy controls. Percentages are based on the average of approximately 1000 total cells counted (see also Supplementary Table 3). Error bars indicate the standard error. Clinical Gastroenterology and Hepatology 2007 5, 574-581.e5DOI: (10.1016/j.cgh.2006.11.014) Copyright © 2007 AGA Institute Terms and Conditions